Medicover (Germany) Performance
| 5M0B Stock | EUR 15.14 0.16 1.05% |
The company secures a Beta (Market Risk) of 0.26, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Medicover's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medicover is expected to be smaller as well. At this point, Medicover AB has a negative expected return of -0.0912%. Please make sure to verify Medicover's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Medicover AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Medicover AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Medicover is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 46.7 M | |
| Total Cashflows From Investing Activities | -333.6 M |
Medicover |
Medicover Relative Risk vs. Return Landscape
If you would invest 1,616 in Medicover AB on September 3, 2024 and sell it today you would lose (102.00) from holding Medicover AB or give up 6.31% of portfolio value over 90 days. Medicover AB is producing return of less than zero assuming 1.36% volatility of returns over the 90 days investment horizon. Simply put, 12% of all stocks have less volatile historical return distribution than Medicover, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Medicover Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medicover's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medicover AB, and traders can use it to determine the average amount a Medicover's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0671
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 5M0B |
Estimated Market Risk
| 1.36 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Medicover is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medicover by adding Medicover to a well-diversified portfolio.
Medicover Fundamentals Growth
Medicover Stock prices reflect investors' perceptions of the future prospects and financial health of Medicover, and Medicover fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medicover Stock performance.
| Return On Equity | 0.0261 | |||
| Return On Asset | 0.024 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 2.94 B | |||
| Shares Outstanding | 71.58 M | |||
| Price To Earning | 46.07 X | |||
| Price To Book | 4.45 X | |||
| Price To Sales | 1.38 X | |||
| Revenue | 1.38 B | |||
| EBITDA | 274.9 M | |||
| Cash And Equivalents | 55.9 M | |||
| Cash Per Share | 0.42 X | |||
| Total Debt | 375.8 M | |||
| Debt To Equity | 116.80 % | |||
| Book Value Per Share | 3.19 X | |||
| Cash Flow From Operations | 216.7 M | |||
| Earnings Per Share | 0.24 X | |||
| Total Asset | 1.68 B | |||
About Medicover Performance
By analyzing Medicover's fundamental ratios, stakeholders can gain valuable insights into Medicover's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Medicover has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medicover has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Medicover AB provides diagnostic and healthcare services in Germany, Romania, Ukraine, Poland, Belarus, Moldova, Serbia, Turkey, Georgia, Bulgaria, India, and Hungary. Medicover AB was founded in 1995 and is headquartered in Stockholm, Sweden. MEDICOVER operates under Health Care Plans classification in Germany and is traded on Frankfurt Stock Exchange. It employs 20970 people.Things to note about Medicover AB performance evaluation
Checking the ongoing alerts about Medicover for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medicover AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medicover AB generated a negative expected return over the last 90 days | |
| Medicover AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Medicover AB has accumulated 375.8 M in total debt with debt to equity ratio (D/E) of 116.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Medicover AB has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Medicover until it has trouble settling it off, either with new capital or with free cash flow. So, Medicover's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medicover AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medicover to invest in growth at high rates of return. When we think about Medicover's use of debt, we should always consider it together with cash and equity. | |
| About 13.0% of Medicover shares are owned by insiders or employees |
- Analyzing Medicover's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medicover's stock is overvalued or undervalued compared to its peers.
- Examining Medicover's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medicover's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medicover's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medicover's stock. These opinions can provide insight into Medicover's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Medicover Stock analysis
When running Medicover's price analysis, check to measure Medicover's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicover is operating at the current time. Most of Medicover's value examination focuses on studying past and present price action to predict the probability of Medicover's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicover's price. Additionally, you may evaluate how the addition of Medicover to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |